Shilpa Medicare’s NorUDCA Makes History as First Approved NAFLD Therapy Worldwide
August 14, 2025
Shilpa Medicare emerges as the global pioneer to receive approval for NorUDCA, offering new hope to over a billion people affected by Non-Alcoholic Fatty Liver